Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Outcomes of NRICM101 on SARS-COV-2 (COVID-19) Infection

NCT04664049 is registered in ClinicalTrials.gov with National Research Institute of Chinese Medicine, Ministry of Health and Welfare as lead sponsor.

NCT NCT04664049
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04664049 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Outcomes of NRICM101 on SARS-COV-2 (COVID-19) Infection
Lead sponsor
National Research Institute of Chinese Medicine, Ministry of Health and Welfare
Phase
Observational
Overall status
Unknown status
Start date
December 23, 2020
Completion date
December 31, 2022
Enrollment
51,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid 19, sars-cov-2